Page 1 of 7 123 ... LastLast
Results 1 to 10 of 67

Thread: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

  1. #1
    EdMurphy is offline Veteran Member (100+ posts)
    Join Date
    Feb 2009
    Posts
    263

    Default Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    Dr Fauci to the rescue, although he hasn't been able to find a vaccine or cure for HIV infection in 33 years:


    5 August 2014 Last updated at 10:40 BST

    One of the world's leading immunologists has told the BBC that he hopes to develop a vaccine for the deadly Ebola virus by the middle to end of 2015.

    Dr Anthony Fauci - the Director of the US National Institute of Allergy and Infectious Diseases - said clinical trials would start in September on a vaccine that has shown "promising results" during tests on animals.
    And of course the imperial BBC is right on the 'bush meat' trail, although they don't point the finger in the direction of the far reaching healthcare privatisation in Sierra Leone and Liberia.

    According to the BBC, "the largely privatised healthcare system is beyond most people's means". (Ignore the BBC's obsession with 'witch doctors'.)

    From Wikipedia, on Sierra Leone's healthcare system, and a map of the areas where ebola has been reported (MAP). National HIV prevalence is set at 1.6%, slightly higher than the Congo DRC at 1.3%, however it is probably lower than that.

    On the privatisation of water in Sierra Leone, from PANOS:

    The International Monetary Fund has ruled strongly in favour of privatising Sierra Leone's state enterprises. In 2001 it made privatisation a condition of its aid package, and also required Sierra Leone to join the Heavily Indebted Poor Country debt relief process. In 2005 the IMF and World Bank approved Sierra Leone's anti-poverty strategies, which included the proposed privatisation of 24 enterprises, including the water authority.

    But privatising a commodity as essential as water in poor countries like Sierra Leone is highly sensitive. Advocates of private sector investment see that as the only choice for moving forward. Critics fear it will mean only those able to afford it will receive water connections while the poor, who cannot afford connection and meter charges, will be left dry.

    The UK is a major donor to Sierra Leone and several UK-based organisations concern themselves with the challenges facing Sierra Leone. "Privatisation means that consumers in developing countries are better off than they were before reform," the London-based Globalisation Institute said in its 2006 report, "Water For Life."

    "They are assured access to a certain amount of water and often receive subsidised amounts beyond that, and they have the benefits of a regular, clean supply to boot," the pro-privatisation think tank added in its report.

    But the UK-based campaigning organisation, the World Development Movement (WDM) claims the poor will not benefit. It has strongly opposed water privatisation in Sierra Leone, and opposes the British government's decision to award a £2.6 million contract in Sierra Leone to Price Waterhouse, accusing the consultancy firm of being biased towards privatisation.
    From the World Bank, on Sierra Leone's far reaching privatisation drive:

    Ongoing privatisation programme

    A chief draw for foreign investors is the government’s privatisation programme through which Sierra Leone aims to attract investors which will bring in signifi- cant capital and technical skills. Sixteen public enterprises across a wide range of sectors are on schedule to undergo major restructuring and be privatised. These companies are Sierra Leone Housing Corporation, Sierra Leone Produce Marketing Board, Mining and General Services, Sierra Leone Road Transport Corporation, Sierra Leone Telecommunications (SIERRATEL), Sierra Leone Airport Authority, National Power Authority, Sierra Leone Ports Authority, Guma Valley Water Company, Sierra Leone National Shipping Company, National Insurance Company, Sierra Leone State Lottery, Sierra Leone Commercial Bank, Sierra Leone Roads Authority, and Rokel Commercial Bank. The National Commission for Privatisation can provide additional information.

  2. #2
    Join Date
    Feb 2009
    Posts
    1,811

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    Thanks Ed.

    Do you have any opinion on Janine Roberts' conjecture that Ebola might not be viral, but may in fact be cyanide poisoning due to proximity to gold mines?

  3. #3
    cdm is offline Veteran Member (100+ posts)
    Join Date
    May 2009
    Location
    Greece
    Posts
    1,551

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    hiv, ebola, hcv, West Nile is the same agenda by the same masterrs of deception. What saves them is that we live in a world full of lies. And these masters are in their kingdom, the kingdom of lies.
    Most people obey to their law of lies, although there are some ''outlaws'' like us who do not obey their law.

  4. #4
    MLW is offline Contributing Member (10-99 posts)
    Join Date
    Aug 2014
    Posts
    94

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    I wonder what softrat thinks of all this.

  5. #5
    Join Date
    Feb 2009
    Posts
    127

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    I have come to a similar conclusion than Janine Roberts but with quicksilver from gold mines, and eventually arsenic.

    I think that bleedings come also from the use of heavy doses of antibiotics to treat ebola cases. Antibiotics are in fact like anticoagulant drugs. They desegregate cells they encounter. Thus, they cause bleeding.

    Probably that both causes are present. It can begin with symptoms coming from cyanides, quicksilver or arsenic. And after that, doctors finish the work with antibiotics.

    At a lower scale, this is the same thing you find about dengue fever. Something like 0,2 to 1 % of the cases end with bleedings. In fact, these cases are the ones where antibiotics have caused bleeding. 99 % of the other cases are just simple nonspecific fever everybody can have. Thus this illness is another pure invention from medicine.
    Aka Aixur, administrator of sidasante.com

  6. #6
    agv's Avatar
    agv is offline Veteran Member (100+ posts)
    Join Date
    Jun 2012
    Posts
    175

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    Jesus...same shit again...

    As I've been reading, hemorragic fever outbreaks are pretty common in this part of the world. They happen all the time. As you are pointing, they are the result of the life and environmental conditions in which this people live.

    Let's see what's coming. I myself don't even care...I don't even read the media anymore and it wasn't until now that I read this post that I got to know about all this.

    So again, feeling thankful for the ones who helped me coming out from the spell, and feeling sorry for the vast majority living under it.

  7. #7
    EdMurphy is offline Veteran Member (100+ posts)
    Join Date
    Feb 2009
    Posts
    263

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    Quote Originally Posted by John Bleau View Post
    Thanks Ed.

    Do you have any opinion on Janine Roberts' conjecture that Ebola might not be viral, but may in fact be cyanide poisoning due to proximity to gold mines?
    Hi John,

    I don't know. There really are hemmorhagic fevers, while at the same time chronic arsenic poisoning has similar effects.

    Meanwhile, more drugs, including a drug formerly banned because of it's side effects.

    (NYTIMES) Second Drug Is Allowed for Treatment of Ebola
    By ANDREW POLLACKAUG. 7, 2014

    The Food and Drug Administration helped clear the way on Thursday for a second experimental drug to be tried by people in Africa stricken with the Ebola virus.

    The drug, being developed by Tekmira Pharmaceuticals of British Columbia, was in the initial phase of human testing, which is on healthy volunteers, when the F.D.A. last month halted the trial because side effects were observed.

    Tekmira announced that the F.D.A., while still saying the drug, called TKM-Ebola, should not be given to healthy volunteers, was now allowing its use to treat patients actually infected with the virus.

    “We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to assist with any responsible use of TKM-Ebola,” Mark Murray, the chief executive of Tekmira, said in a statement. “The foresight shown by the F.D.A. removes one potential roadblock to doing so.”

    He said the company was evaluating options for use of the drug, which is being developed under a $140 million contract from the Defense Department.

    The drug works by shutting off genes of the virus using a technique called RNA interference. Earlier this week there were reports that a different experimental medicine, made by Mapp Biopharmaceutical of San Diego, appeared to be helping two American aid workers who had been stricken by the disease. Mapp and federal agencies are looking to provide that drug, called ZMapp, to sick people in Africa.

    But supplies of both ZMapp and TKM-Ebola are limited. And there are various other obstacles, such as regulatory ones, to be surmounted before the drugs can be used in Africa.

    A version of this article appears in print on August 8, 2014, on page A11 of the New York edition with the headline: Second Drug Is Allowed for Treatment of Ebola.

  8. #8
    Join Date
    Feb 2009
    Posts
    127

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    With this new drug (the Zmapp) suddenly introduced, we can think that the goal of the Ebola scam created 40 years ago was from the beginning to sell this drug, and probably later on, a vaccine.

    Of course, for the moment, nothing is certain about the commercialization of the Zmapp or other drugs. So, we can't be sure about the true nature of this scam. But there is now an important suspicion about it.
    Aka Aixur, administrator of sidasante.com

  9. #9
    Join Date
    Feb 2009
    Posts
    2,029

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    Quote Originally Posted by EdMurphy View Post
    Hi John,

    I don't know. There really are hemmorhagic fevers, while at the same time chronic arsenic poisoning has similar effects...
    I agree that the evidence for this seems solid, but remember, the best science can do is to claim that a notion is a theory. Just about anything that stresses the body can make it more susceptible to various diseases/conditions, and it may be that those who die of Ebola are much more likely to have raised levels of certain toxins in their bodies, but that still needs to be investigated, especially among the doctors who became ill.

  10. #10
    EdMurphy is offline Veteran Member (100+ posts)
    Join Date
    Feb 2009
    Posts
    263

    Default Re: Ebola, Healthcare Privatisation In Sierra Leone and Anthony Fauci Returns

    Hi Alain,

    Another interesting angle is the bio-warfare angle:

    (GLOBALRESEARCH) West Africa: What are US Biological Warfare Researchers Doing in the Ebola Zone?
    By Jon Rappoport
    Global Research, August 02, 2014
    jonrappoport.wordpress.com/
    Region: sub-Saharan Africa
    Theme: Biotechnology and GMO, Militarization and WMD, Science and Medicine

    This is a call for an immediate, thorough, and independent investigation of Tulane University researchers (see here and here) and their Fort Detrick associates in the US biowarfare research community, who have been operating in West Africa during the past several years.

    What exactly have they been doing?

    Exactly what diagnostic tests have they been performing on citizens of Sierra Leone?

    Why do we have reports that the government of Sierra Leone has recently told Tulane researchers to stop this testing?

    Have Tulane researchers and their associates attempted any experimental treatments (e.g., injecting monoclonal antibodies) using citizens of the region? If so, what adverse events have occurred?

    The research program, occurring in Sierra Leone, the Republic of Guinea, and Liberia—said to be the epicenter of the 2014 Ebola outbreak—has the announced purpose, among others, of detecting the future use of fever-viruses as bioweapons.

    Is this purely defensive research? Or as we have seen in the past, is this research being covertly used to develop offensive bioweapons?

    For the last several years, researchers from Tulane University have been active in the African areas where Ebola is said to have broken out in 2014.

    These researchers are working with other institutions, one of which is USAMRIID, the US Army Medical Research Institute of Infectious Diseases, a well-known center for biowar research, located at Fort Detrick, Maryland.

    In Sierra Leone, the Tulane group has been researching new diagnostic tests for hemorrhagic fevers.

    Note: Lassa Fever, Ebola, and other labels are applied to a spectrum of illness that result in hemorrhaging.

    Tulane researchers have also been investigating the use of monoclonal antibodies as a treatment for these fevers—but not on-site in Africa, according to Tulane press releases.

    Here are excerpts from supporting documents.

    Tulane University, Oct. 12, 2012, “Dean’s Update: Update on Lassa Fever Research” (.pdf here):

    “In 2009, researchers received a five-year $7,073,538 grant from the National Institute of Health to fund the continued development of detection kits for Lassa viral hemorrhagic fever.

    “Since that time, much has been done to study the disease. Dr. Robert Garry, Professor of Microbiology and Immunology, and Dr. James Robinson, Professor of Pediatrics, have been involved in the research of Lassa fever. Together the two have recently been able to create what are called human monoclonal antibodies. After isolating the B-cells from patients that have survived the disease, they have utilized molecular cloning methods to isolate the antibodies and reproduce them in the laboratory. These antibodies have been tested on guinea pigs at The University of Texas Medical Branch in Galveston and shown to help prevent them from dying of Lassa fever…

    “Most recently, a new Lassa fever ward is being constructed in Sierra Leone at the Kenema Government Hospital. When finished, it will be better equipped to assist patients affected by the disease and will hopefully help to end the spread of it.” [The Kenema Hospital is one of the centers of the Ebola outbreak.]
    Here is another release from Tulane University, this one dated Oct. 18, 2007.


    “New Test Moves Forward to Detect Bioterrorism Threats.”


    “The initial round of clinical testing has been completed for the first diagnostic test kits that will aid in bioterrorism defense against a deadly viral disease. Tulane University researchers are collaborating in the project.

    Robert Garry, professor of microbiology and immunology at Tulane University, is principal investigator in a federally funded study to develop new tests for viral hemorrhagic fevers.

    Corgenix Medical Corp., a worldwide developer and marketer of diagnostic test kits, announced that the first test kits for detection of hemorrhagic fever have competed initial clinical testing in West Africa.

    “The kits, developed under a $3.8 million grant awarded by the National Institutes of Health, involve work by Corgenix in collaboration with Tulane University, the U.S. Army Medical Research Institute of Infectious Diseases, BioFactura Inc. and Autoimmune Technologies.

    “Clinical reports from the studies in Sierra Leone continue to show amazing results,” says Robert Garry, professor of microbiology and immunology at the Tulane University School of Medicine and principal investigator of the grant.

    “We believe this remarkable collaboration will result in detection products that will truly have a meaningful impact on the healthcare in West Africa, but will also fill a badly needed gap in the bioterrorism defense.

    “…The clinical studies are being conducted at the Mano River Union Lassa Fever Network in Sierra Leone. Tulane, under contract with the World Health Organization, implements the program in the Mano River Union countries (Sierra Leone, Liberia and Guinea) to develop national and regional prevention and control strategies for Lassa fever and other important regional diseases.

    “Clinical testing on the new recombinant technology demonstrates that our collaboration is working,” says Douglass Simpson, president of Corgenix. “We have combined the skills of different parties, resulting in development of some remarkable test kits in a surprisingly short period of time. As a group we intend to expand this program to address other important infectious agents with both clinical health issues and threat of bioterrorism such as ebola.”

    The third document is found on the Sierra Leone Ministry of Health and Sanitation Facebook page (no login required), dated July 23 at 1:35pm. It lays out emergency measures to be taken. We find this curious statement: “Tulane University to stop Ebola testing during the current Ebola outbreak.”

    Why? Are the tests issuing false results? Are they frightening the population? Have Tulane researchers done something to endanger public health?

    In addition to an investigation of these matters, another probe needs to be launched into all vaccine campaigns in the Ebola Zone. For example. HPV vaccine programs have been ongoing. Vials of vaccine must be tested to discover ALL ingredients. Additionally, it’s well known that giving vaccines to people whose immune systems are already severely compromised is dangerous and deadly.

    Thanks to birdflu666.wordpress.com for discovering hidden elements of the Ebola story.

    Jon Rappoport

    The author of three explosive collections, THE MATRIX REVEALED, EXIT FROM THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US Congressional seat in the 29th District of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free emails at www.nomorefakenews.com

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •